Scn2a-related Epileptic Encephalopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-10-02
Clinical Trial Update: A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety [Phase 3]
Praxis Precision Medicines is conducting a Phase 3 trial of Elsunersen in children with SCN2A-related epileptic encephalopathy to assess eff…